Literature DB >> 3768092

Discrepancies between the outcome of animal and human studies on the mode of action of probucol.

A C Beynen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768092     DOI: 10.1016/0021-9150(86)90146-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.

Authors:  S H Zhang; R L Reddick; E Avdievich; L K Surles; R G Jones; J B Reynolds; S H Quarfordt; N Maeda
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 2.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.